Extreme Movers: Grok 4.7's picks for 2026-10-27
Grok 4.7 picked RRC, SGRY, XNCR, XP, FICO for a 1-day horizon. Average directional return: +1.66%. Directions called correctly: 80%.
| Experiment | Extreme Movers |
|---|---|
| Model | Grok 4.7 |
| Prompt version | extreme-movers-v11 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-27 |
| Measured to | 2026-10-28 |
| Benchmark | SPY |
| Status | Settled |
| Average directional return | +1.66% |
| Directions called correctly | 80% |
| Benchmark return | +0.58% |
The picks
| Rank | Symbol | Direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | RRC | up | +1.82% | +1.82% | 82% | +1.25% | Yes |
| 2 | SGRY | up | +0.45% | +0.45% | 78% | -0.12% | Yes |
| 3 | XNCR | up | +7.65% | +7.65% | 74% | +7.07% | Yes |
| 4 | XP | up | -2.33% | -2.33% | 68% | -2.91% | No |
| 5 | FICO | down | -0.73% | +0.73% | 65% | +0.15% | Yes |
The model's market view
Monday session mixed with AI and deal-driven gains offset by political and pricing shocks; expect selective follow-through on substantive catalysts while political overreactions may reverse.
Why each pick
RRC
Range Resources surged 17.66% on October 26 after EQT agreed to acquire it in a $13 billion all-stock deal (0.987 EQT shares per RRC share, ~20.6% premium) creating a >$50B enterprise-value natural-gas leader with expected $325M annual synergies. Catalyst is substantive and binary (shareholder/regulatory approval path to Q1 2027 close). Latest intraday quote ~$53.0–53.8 on October 27 (pre-market/open near prior close of $53.56); 20-day average volume ~3–5M shares yields dollar volume well above $20M floor at recent prices. Expect continuation higher as deal premium holds and energy sentiment remains constructive.
SGRY
Surgery Partners jumped 47.62% on October 26 after HealthSpan Partners (affiliate of Bon Secours Mercy Health) agreed to acquire it for approximately $5.7 billion. Catalyst is substantive (definitive acquisition announcement). Latest intraday quote $23.18 on October 27 (market open, near prior close of $23.25); market cap ~$3.01–3.04B and 20-day average volume ~4.6M shares produce dollar volume >$20M. Deal premium supports continuation of the upward move absent adverse developments.
XNCR
Xencor rose 15.89% on October 26 after presenting updated Phase 1 data for XmAb819 (ENPP3 x CD3 bispecific) in advanced clear-cell renal cell carcinoma at ESMO, showing 45.5% confirmed ORR at the proposed Phase 3 dose and supporting further development. Catalyst is substantive (clinical results and Phase 3 plans). Latest quote near $29.2–29.6 on October 27 (pre-market/open near prior close of $29.18); market cap ~$2.17B and elevated volume (day volume ~8.9M vs typical ~1.5M) confirm liquidity well above $20M 20-day average dollar volume. Positive data flow supports continuation higher.
XP
XP Inc. plunged 48.36% on October 26 after Luiz Inácio Lula da Silva’s unexpected re-election victory in Brazil triggered a broad sell-off in Brazilian equities and fintech names on fears of less market-friendly policy. Catalyst is speculative/political rather than company-specific fundamental deterioration (earnings remain solid). Latest intraday quote $16.43 on October 27 (market open, up from prior close of $15.71); market cap ~$8.3B and high volume (day ~133M shares, 20-day average ~10M+) confirm liquidity. Large oversold move on political event favors a reversal bounce.
FICO
Fair Isaac fell 13.15% on October 26 after announcing a Preferred Program that locks mortgage-score pricing at $10 for committed lenders and after multiple analyst downgrades/price-target cuts citing reduced pricing power versus VantageScore 4.0 under updated FHFA rules. Catalyst is substantive (pricing concession and competitive/regulatory pressure). Latest intraday quote ~$707.56 on October 27 (near prior close of $708.07); market cap ~$15.28B and 20-day average volume ~0.7–1.1M shares yield dollar volume well above $20M. Ongoing concerns support continuation lower into the November 4 earnings.
Other models on the same run
| Model | Picks | Average directional return | Directions called correctly |
|---|---|---|---|
| Gemini 3 Pro | CLS, LITE, FICO, COHR, BE | +3.12% | 80% |
| Perplexity | NU, MELI, DASH, FIX, BE | -0.63% | 40% |
| Muse Spark 1.1 | SOFI, CLS, MRNA, INOD, XYL | +8.27% | 100% |
| Claude Sonnet 5.5 | NU, XP, TENB, RRC, FICO | +0.18% | 60% |
| DeepSeek | LITE, TSLA, FICO, COHR, DASH | +1.58% | 60% |
Written up on ForecastNest Insights: Extreme Movers: Grok 4.7's picks for 2026-10-27.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.